• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一个由复合杂合突变导致遗传性凝血因子Ⅴ缺乏症的家系的表型与基因型分析]

[Analysis of Phenotype and Genotype of A Family with Hereditary Coagulation Factor Ⅴ Deficiency Caused by A Compound Heterozygous Mutation].

作者信息

Kong Rong-Xia, Xie Yao-Sheng, Xie Hai-Xiao, Luo Sha-Sha, Wang Ming-Shan

机构信息

Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, Zhejiang Province, China.

Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, Zhejiang Province, China,E-mail:

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Dec;28(6):2033-2038. doi: 10.19746/j.cnki.issn.1009-2137.2020.06.039.

DOI:10.19746/j.cnki.issn.1009-2137.2020.06.039
PMID:33283738
Abstract

OBJECTIVE

To analyze the molecular pathogenesis by analysis of phenotype and gene mutation in families with hereditary coagulation factor V (FⅤ) defect caused by complex heterozygous mutation.

METHODS

Plasma pro-thrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), FⅤ procoagulant activity (FⅤ∶C), FⅤ antigen (FⅤ∶Ag), and other related coagulation indexes were detected in the proband and his family members (3 generations 10 people). Using DNA direct sequencing to analyze all exons, flanks, 5' and 3' untranslated regions of F5 genes and the corresponding mutation site regions of family members, the mutation site was confirmed by reverse sequencing.The conservation of mutant amino acids was analyzed by ClustalX-2.1-win software. The PROVEAN and MutationTaster online bioinformatics software were used to predict the effect of mutation on protein function. Protein model and amino acid interaction at mutation sites was analyzed by Swiss-pdbviewer software.

RESULTS

The PT and APTT of the proband were significantly prolonged compared with healthy controls (34.2 vs 13.2 s and 119.3 vs 36.0 s), while FⅤ∶C and FⅤ∶Ag extremely reduced (3% and 6%). The PT and APTT of the second-born, the third son, daughter, and grandson of the proband were slightly prolonged, and the FⅤ∶C and FⅤ∶Ag decreased to varying degrees. The related coagulant parameters of other family members were within normal range. Genetic analysis revealed that the proband had a c.911G>A heterozygous missense mutation on the exon 6 lead to p.Gly276Glu, and a c.5343C>G heterozygous missense mutation on the exon 16 lead to p.Ser1781Arg of the proband. The second-born, the third son, and grandson of the proband carry p.Gly276Glu heterozygotes, and the daughter carries p.Ser1781Arg heterozygotes, while the other family members were wild-type. The results of conservative analysis indicated that p.Gly276 and p.Ser1781 were highly conserved in homologous species. The two bioinformatics software predicted the same results, PROVEAN (score -6.214 and -12.79) indicated that the compound heterozygous mutation was a harmful mutation; MutationTaster (score 0.976 and 0.999) suggested that these mutations might cause corresponding disease. p.Gly276Glu protein model analysis showed that, the Glu side chain was prolonged and the molecular weight became larger, which would increase the steric hindrance between it and the surrounding amino acids, affect the normal local folding of the FⅤ protein, and eventually lead to the decrease of protein activity and content. This paper can not provide analysis of the spatial structure of p.Ser1781Arg mutant protein because of the lack of X ray 3 D structure file of FⅤ exon 16.

CONCLUSION

The new compound heterozygous mutations (p.Gly276Glu and p.Ser1781Arg) identified in this study are the main reasons for the decrease in the FⅤ level of the family, among which p.Ser1781Arg is rarely reported at home and abroad.

摘要

目的

通过对复合杂合突变导致的遗传性凝血因子V(FⅤ)缺陷家系的表型和基因突变分析,探讨其分子发病机制。

方法

检测先证者及其家系成员(3代10人)血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、FⅤ促凝活性(FⅤ∶C)、FⅤ抗原(FⅤ∶Ag)及其他相关凝血指标。采用DNA直接测序法分析F5基因所有外显子、侧翼序列、5′和3′非翻译区以及家系成员相应突变位点区域,反向测序验证突变位点。利用ClustalX-2.1-win软件分析突变氨基酸的保守性。使用PROVEAN和MutationTaster在线生物信息学软件预测突变对蛋白质功能的影响。通过Swiss-pdbviewer软件分析突变位点的蛋白质模型和氨基酸相互作用。

结果

先证者PT和APTT较健康对照显著延长(34.2 vs 13.2 s和119.3 vs 36.0 s),而FⅤ∶C和FⅤ∶Ag极度降低(3%和6%)。先证者的次子、三子、女儿和孙子PT和APTT轻度延长,FⅤ∶C和FⅤ∶Ag不同程度降低。其他家系成员相关凝血参数在正常范围。基因分析显示,先证者外显子6存在c.911G>A杂合错义突变,导致p.Gly276Glu,外显子16存在c.5343C>G杂合错义突变,导致p.Ser1781Arg。先证者的次子、三子和孙子携带p.Gly276Glu杂合子,女儿携带p.Ser1781Arg杂合子,其他家系成员为野生型。保守性分析结果表明,p.Gly276和p.Ser1781在同源物种中高度保守。两个生物信息学软件预测结果一致,PROVEAN(评分-6.214和-12.79)表明复合杂合突变是有害突变;MutationTaster(评分0.976和0.999)提示这些突变可能导致相应疾病。p.Gly276Glu蛋白质模型分析显示,Glu侧链延长,分子量增大,会增加其与周围氨基酸之间的空间位阻,影响FⅤ蛋白正常局部折叠,最终导致蛋白活性和含量降低。因缺乏FⅤ外显子16的X射线三维结构文件,本文无法提供p.Ser1781Arg突变蛋白的空间结构分析。

结论

本研究鉴定的新复合杂合突变(p.Gly276Glu和p.Ser1781Arg)是该家系FⅤ水平降低的主要原因,其中p.Ser1781Arg在国内外鲜有报道。

相似文献

1
[Analysis of Phenotype and Genotype of A Family with Hereditary Coagulation Factor Ⅴ Deficiency Caused by A Compound Heterozygous Mutation].[一个由复合杂合突变导致遗传性凝血因子Ⅴ缺乏症的家系的表型与基因型分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Dec;28(6):2033-2038. doi: 10.19746/j.cnki.issn.1009-2137.2020.06.039.
2
[Phenotypic and mutational analysis of a pedigree affected with hereditary coagulation factor Ⅴ deficiency].[一个遗传性凝血因子Ⅴ缺乏症家系的表型和突变分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):202-206. doi: 10.3760/cma.j.issn.1003-9406.2018.02.012.
3
[The analysis of a pedigree with hereditary coagulation factor Ⅴ deficiency caused by compound heterozygous variation of F5 gene].[F5基因复合杂合变异导致遗传性凝血因子Ⅴ缺乏症的家系分析]
Zhonghua Yi Xue Za Zhi. 2023 May 9;103(17):1323-1327. doi: 10.3760/cma.j.cn112137-20220828-01821.
4
[Phenotype and Genotype Analysis in Two Pedigrees with Hereditary Coagulation Factor Ⅺ Deficiency].[两个遗传性凝血因子Ⅺ缺乏家系的表型与基因型分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 Mar;51(2):252-256. doi: 10.12182/20200360601.
5
[Identification of compound heterozygous mutations of F11 gene in a pedigree affected with heriditary coagulation factor XI deficiency].[一个遗传性凝血因子XI缺乏症家系中F11基因复合杂合突变的鉴定]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Apr 10;36(4):363-367. doi: 10.3760/cma.j.issn.1003-9406.2019.04.018.
6
Analysis of phenotype and genotype of a family with hereditary coagulation factor V deficiency caused by the compound heterozygous mutations.遗传性凝血因子 V 缺乏症一家系的表型与基因型分析:复合杂合突变所致。
Blood Coagul Fibrinolysis. 2020 Oct;31(7):485-489. doi: 10.1097/MBC.0000000000000946.
7
[Analysis of A Pedigree with Hereditary Coagulation Factor Ⅻ Deficiency Caused by Compound Heterozygous Mutations].[复合杂合突变导致遗传性凝血因子Ⅻ缺乏症家系分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Apr;30(2):571-576. doi: 10.19746/j.cnki.issn.1009-2137.2022.02.042.
8
[Analysis of a pedigree with inherited factor V deficiency caused by compound heterozygous mutation].[复合杂合突变导致遗传性因子V缺乏症的家系分析]
Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):135-139. doi: 10.3760/cma.j.issn.0253-2727.2021.02.008.
9
[Analysis of a pedigree affected with hereditary coagulation factor XI deficiency due to compound heterozygous variants of F11 gene].[F11基因复合杂合变异导致的遗传性凝血因子XI缺乏症家系分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Mar 10;38(3):242-246. doi: 10.3760/cma.j.cn511374-20200123-00047.
10
[Phenotype and genotype analyses of two pedigrees with inherited fibrinogen deficiency].[两个遗传性纤维蛋白原缺乏症家系的表型和基因型分析]
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):930-935. doi: 10.3760/cma.j.issn.0253-2727.2023.11.008.

引用本文的文献

1
High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies.高突变异质性,以及人类凝血因子 V 基因中的新突变。使用重组和先进疗法治疗因子 V 缺乏症的未来展望。
Int J Mol Sci. 2021 Sep 8;22(18):9705. doi: 10.3390/ijms22189705.